↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

98 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Abatacept  27件: Abatacept; Abatacept injection; Bms 188667 (abatacept); Abatacept (aba) + methotrexate (mtx), double-blind (db); Abatacept (bms-188667); Abatacept (iv); Abatacept + csdmard; Abatacept + methotrexate; Abatacept + vaccines; Abatacept placebo; Abatacept prefilled syringe; Abatacept, rituximab or tocilizumab; Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Decrease tocilizumab, abatacept; Double-blind abatacept; Intravenous (iv) abatacept; Iv abatacept; Open-label abatacept; Orencia (abatacept); Orencia abatacept; Subcutaneous (sc) abatacept; Subcutaneous abatacept; Subcutaneous(sc) abatacept; Tocilizumab, abatacept; Abatacept subcutaneous; Abatacept sc; Abatacept (aba);   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300
 2   Abituzumab  3件: Abituzumab; Abituzumab 1500 mg; Abituzumab 500 mg;   -   -   -   1件:
51
 3   Acetaminophen  8件: Acetaminophen; Acetaminophen tab 650mg; Acetaminophen/paracetamol; Acetaminophen tablets; Paracetamol (acetaminophen); Tramadol hydrochloride + acetaminophen; Oxycodone/acetaminophen; Tramadol /acetaminophen;   D00217   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   13件:
3,
6,
13,
34,
35,
46,
49,
51,
70,
86,
231,
256,
271
 4   Acetate  81件: Acetate; Leuprorelin acetate; 40 mg glatiramer acetate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Flecainide acetate; Oxaloacetate (oaa); Ulipristal acetate; 11c-acetate; 20mg/0.5ml glatiramer acetate; Bazedoxifene acetate; Cyclophosphamide/glatiramer acetate; Dirucotide acetate; Experimental glatiramer acetate; Glatiramer acetate; Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Human interferon beta-1a and glatiramer acetate; Nomegestrol acetate; Plovamer acetate; Prednisone acetate; Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate; Tocopherol acetate; Depot leuprolide acetate 3.75 mg; Caspofungin acetate; Desmopressin acetate; Lanreotide acetate; Abiraterone acetate; Gonadorelin acetate and triptorelin acetate; Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Leuprorelin acetate 3.75mg injection; Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Megestrol acetate; Megestrol acetate tablet; Triptorelin acetate and gonadorelin acetate; Macimorelin acetate; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortisone acetate; Hydrocortisone sodium acetate; Sodium acetate; Tetracosactide acetate; 11c acetate; Dichloroacetate; Dichloroacetate sodium; Zuretinol acetate; Etiprednol dicloacetate; Delmitide acetate; L-lysyl-d-prolyl-l-threonine acetate; Sotrastaurin (inn) acetate; Cosyntropin acetate; Tetracosactide hexaacetate; Glatiramer acetate (copaxone®); Zinc acetate; Zinc acetate dihydrate; Tocopheryl acetate; Prednisolone acetate; Prednisone acetate tablets; Desmopressin acetate trihydrate; Phosphate and betamethasone acetate, 2 ml.; [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate; Loestrin (norethindrone acetate and ethinyl estradiol); Zinc acetate (20mg/d);   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299
 5   Acetylcysteine  8件: Acetylcysteine; N-acetylcysteine; N-acetylcysteine capsule; Glatiramer acetate, n-acetylcysteine; N acetylcysteine; N-acetylcysteine (nac); N-acetylcysteine, (nac); Acetylcysteine sodium;   D00221   -   -   16件:
6,
13,
19,
20,
49,
51,
58,
85,
94,
96,
97,
111,
164,
233,
298,
299
 6   Acetylsalicylic acid  2件: Acetylsalicylic acid; Acetylsalicylic acid at 1st visit,;   D00109   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   10件:
13,
22,
34,
46,
49,
51,
86,
113,
158,
231
 7   Acotiamide  1件: Acotiamide;   -   -   -   1件:
51
 8   Ajulemic acid  2件: Ajulemic acid; Resunab, ajulemic acid, anabasum;   D11312   1件: CNR2   1件: Neuroactive ligand-receptor interaction   3件:
50,
51,
299
 9   Alemtuzumab  18件: Alemtuzumab; Alemtuzumab (gz402673); Alemtuzumab 12 mg; Alemtuzumab 24 mg; Alemtuzumab gz402673; Alemtuzumab immunotherapy; Alemtuzumab injection [lemtrada]; Alemtuzumab (campath); Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994; Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994); Alemtuzumab (campath ); Alemtuzumab and rituximab; Alemtuzumab, rituximab; Alemtuzumab 0.2 mg; Alemtuzumab 0.3 mg; Filgrastim, alemtuzumab; Transplant conditioning with mobilization and alemtuzumab; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan;   D02802   -   -   17件:
13,
15,
19,
20,
46,
49,
51,
60,
63,
65,
85,
96,
164,
234,
284,
285,
326
 10   Alginic acid  1件: Alginic acid;   D02324   -   -   3件:
51,
53,
299
 11   Alprostadil  1件: Alprostadil;   D00180
 D02705 
 1件: PTGER1   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   2件:
51,
70
 12   Ambrisentan  8件: Ambrisentan; Tadalafil and ambrisentan upfront combination therapy; Ambrisentan - high dose; Ambrisentan - low dose; Ambrisentan 5 mg film-coated tablets; Ambrisentan plus spironolactone; Bosentan, ambrisentan; Ambrisentan 5 mg;   D07077   1件: EDNRA   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   6件:
51,
84,
85,
86,
88,
211
 13   Amlodipine  4件: Amlodipine; Amlodipine gel; Calcium channel blockers (amlodipine, azelnidipine); Amlodipine (drug);   D00615
 D02914
 D07450 
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   4件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Cardiac muscle contraction, Vascular smooth muscle contraction   4件:
51,
65,
67,
298
 14   Atorvastatin  9件: Atorvastatin; Interferon beta treatment to add-on atorvastatin treatment; Interferon beta-1b/atorvastatin group; Untreated to atorvastatin treatment; Atorvastatin tablet 20 mg; Atorvastatin 10mg; Atorvastatin 20mg; Lisinopril, losartan, and atorvastatin; Atorvastatin calcium;   D00258
 D00887
 D07474 
 1件: HMGCR   1件: Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299
 15   Aviptadil  2件: Aviptadil; Aviptadil, 66 microgram/ml;   -   -   -   4件:
49,
51,
85,
86
 16   BMS-986020  1件: Bms-986020;   -   -   -   2件:
51,
85
 17   Belimumab  21件: Belimumab; Benlysta (belimumab); Benlysta® (belimumab); Belimumab 10 mg/kg; Belimumab 1 mg/kg; Belimumab 4 mg/kg; Belimumab 10 mg/kg plus standard therapy; Belimumab 100 mg sc; Belimumab 10mg/kg; Belimumab 200 mg sc; Belimumab 200 mg/ml; Belimumab for iv; Belimumab for sc; Belimumab injection; Belimumab or benlysta; Belimumab plus early vaccination; Belimumab plus late vaccination; Benlysta™ (belimumab); Sc belimumab 200 mg; Belimumab 10 mg; Gsk1550188 (belimumab);   D03068   1件: TNFSF13B   2件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway   8件:
11,
43,
44,
46,
49,
51,
53,
222
 18   Bortezomib  6件: Bortezomib; Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone; Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Combination of a single dose anti-cd20 antibody and bortezomib; Bortezomib (velcade®);   D03150   1件: PSMB5   1件: Proteasome   13件:
11,
26,
28,
46,
49,
51,
61,
63,
66,
228,
256,
288,
331
 19   Bosentan  14件: Bosentan; Bosentan mylan; Bosentan (tracleer); Bosentan 125 mg; Bosentan 62.5 mg; Bosentan group; Bosentan monohydrate; Sildenafil 20mg and bosentan 62.5mg; Bosentan administration; Bosentan and sildenafil; Bosentan monohydrat; Bosentan, ambrisentan; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Sildenafil singly or in association with bosentan;   D01227
 D07538 
 2件: EDNRA, EDNRB   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   10件:
13,
41,
47,
51,
84,
85,
86,
88,
210,
211
 20   Botulinum Toxin Type B  3件: Botulinum toxin type b; Botulinum toxin type b (myobloc); Botulinum toxin type b (2500 units / vial);   D02735   1件: SNAP25   1件: Synaptic vesicle cycle   3件:
2,
6,
51
 21   Botulinum toxin type A  3件: Botulinum toxin type a; Clostridium botulinum toxin type a; Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle;   D00783   1件: SNAP25   1件: Synaptic vesicle cycle   13件:
2,
5,
6,
7,
13,
15,
17,
36,
51,
70,
113,
149,
226
 22   Brentuximab vedotin  1件: Brentuximab vedotin;   D09587   1件: TNFRSF8   1件: Cytokine-cytokine receptor interaction   2件:
49,
51
 23   Brodalumab  1件: Brodalumab;   D10061   1件: IL17RA   2件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway   2件:
37,
51
 24   Buspirone  2件: Buspirone; Buspirone hydrochloride;   D00702
 D07593 
 2件: DRD2, HTR1A   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Serotonergic synapse   2件:
6,
51
 25   Busulfan  13件: Busulfan; Busulfan, cyclophosphamide, antithymocyte globulin; Busulfan, cyclophosphamide, atg; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Fludarabine/busulfan; Busulfan iv; Busulfan, cyclophosphamide, atg, gcsf; Busulfan, fludarabine and atg; Busulfan, fludarabine, atg, tli; Fludarabine, busulfan, thymoglobulin; Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen); Campath, busulfan, clofarabine;   D00248   -   -   13件:
19,
20,
28,
36,
49,
51,
60,
65,
164,
274,
284,
285,
326
 26   Butyric Acid  0件:   D05866   -   -   5件:
34,
51,
56,
97,
291
 27   Calcium  26件: Calcium; Calcium carbonate; Calcium levofolinate; Ascal(r) / carbasalate calcium; Calcium and cholecalciferol; Calcium citrate; Carbasalate calcium; Ethylhydrogenfumarat, calciumsalz; Ibandronate+alfacalcidol+calcium; Rosuvastatin calcium; Calcium channel blockers; Calcium channel blockers (amlodipine, azelnidipine); Calcium rosuvastatin; Crestor tablets (calcium rosuvastatin) film-coated tablets; Calcium citrate with vitamin d2; Vidofludimus calcium; Calcium gluconate; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin); Low molecular weight heparin calcium injection; Amorphous calcium carbonate; Calcitriol & calcium; Calcium carbonate and alphacalcidol; Calcium lactate; Crystalline calcium supplements; Atorvastatin calcium; Calcium, dietary;   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299
 28   Cetuximab  1件: Cetuximab;   D03455   1件: EGFR   3件: ErbB signaling pathway, MAPK signaling pathway, Pathways in cancer   5件:
34,
51,
86,
89,
331
 29   Chloride ion  0件:   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299
 30   Cilostazol  1件: Cilostazol;   D01896   3件: PDE3A, PDE3B, TBXA2R   6件: Glucagon signaling pathway, Insulin signaling pathway, Platelet activation, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
51,
70
 31   Coenzyme M  0件:   -   -   -   9件:
13,
44,
45,
49,
51,
60,
65,
96,
164
 32   Cyclophosphamide  49件: Cyclophosphamide; Cyclophosphamide (drug); Cyclophosphamide and atg; Cyclophosphamide monohydrate; Cyclophosphamide/glatiramer acetate; Busulfan, cyclophosphamide, antithymocyte globulin; Busulfan, cyclophosphamide, atg; Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Lenalidomide, dexamethasone and cyclophosphamide; Rituximab and cyclophosphamide iv; Prednisone, cyclophosphamide; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Cyclophosphamide-prednisone-azathioprine; Iv cyclophosphamide; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Cyclophosphamide (cy); Cyclophosphamide (cy) (plan 1); Cyclophosphamide (cy) (plan 2); Cyclophosphamide 100mg; Cyclophosphamide 150mg; Cyclophosphamide 50mg; Cyclophosphamide, fludarabine , thymoglobulin; Cyclophosphamide, fludarabine, rabbit atg; Cyclophosphamide, fludarabine, thymoglobulin; Cyclophosphamide,campath ih and tbi; Cyclophosphamide,cyclosporine a; Fludarabine, cyclophosphamide; Haploidentical hsct using tbi free regimen, ''atg'' with ''post transplant cyclophosphamide''; Busulfan, cyclophosphamide, atg, gcsf; Campath, fludarabine, cyclophosphamide; Cyclophosphamide 30; Cyclophosphamide 40; Cyclophosphamide dose level 1; Cyclophosphamide dose level 2; Cyclophosphamide dose level 3; Cyclophosphamide dose level 4; Cyclophosphamide post transplant; Prednisone and cyclophosphamide; Prednisone plus cyclophosphamide; High-dose cyclophosphamide; Cyclophosphamide 50mg oral tablet; Cyclophosphamide and steroids; Cyclophosphamide(ctx); Cyclophosphamide + pred; Cyclophosphamide, fludarabine; Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen); Thalidomide, cyclophosphamide and prednisone;   D00287
 D07760 
 -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331
 33   Dimethyl fumarate  4件: Dimethyl fumarate; Dimethyl fumarate (dmf); Dimethyl fumarate [dmf]; Tecifdera (dimethyl fumarate);   D03846   -   -   5件:
13,
46,
49,
51,
86
 34   Diphenhydramine  1件: Diphenhydramine;   D00300
 D00669
 D02419
 D03285
 D03360
 D03854 
 1件: HRH1   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   5件:
49,
51,
70,
86,
256
 35   Dipyridamole  7件: Amoxapine & dipyridamole; Dipyridamole; Prednisolone & dipyridamole; Prednisolone-dipyridamole; Z102 (prednisolone and dipyridamole).; Extended release dipyridamole 200mg/aspirin 25mg; Dipyridamole tab 25 mg;   D00302   2件: PDE4A, PDE5A   2件: cAMP signaling pathway, cGMP-PKG signaling pathway   5件:
46,
49,
51,
66,
224
 36   Domperidone  3件: Domperidone; Domperidone (drug); Levodopa and domperidone;   D01745
 D07868 
 1件: DRD2   2件: Dopaminergic synapse, Neuroactive ligand-receptor interaction   5件:
6,
13,
17,
51,
230
 37   Ethanol  14件: Endocannabinoid palmitoylethanolamide (pea); Palmitoylethanolamide; Treprostinil diethanolamine; Ut-15c (treprostinil diethanolamine); Ut-15c sr (treprostinil diethanolamine); Andrographis paniculata (ethanol extract); Ethanol; Ethanol (96 per cent); Ethanol 96% gel; Ethanol 98% solution; Ethanol bp; Ethanol gel; Ethanolamine; Ethanolamine oleate;   D00068
 D02798
 D04855
 D06542 
 -   -   49件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
58,
61,
63,
64,
65,
66,
81,
84,
85,
86,
88,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
279,
280,
283,
284,
285,
288,
298,
299,
300,
331
 38   Factor XIII (human)  0件:   -   -   -   1件:
51
 39   Fibrinolysin  0件:   D07422   -   -   2件:
51,
288
 40   Filgrastim  7件: Filgrastim; Pegfilgrastim; Ep2006 (filgrastim); Filgrastim hexal; Filgrastim, alemtuzumab; Granulocyte colony-stimulating factor (filgrastim); Filgrastim (g-csf);   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   28件:
2,
6,
13,
16,
25,
26,
28,
34,
35,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
85,
96,
113,
164,
283,
284,
285,
331
 41   Fludarabine  23件: Fludarabine; Fludarabine phosphate; Fludarabine monophosphate; Sq fludarabine; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Cyclophosphamide, fludarabine , thymoglobulin; Cyclophosphamide, fludarabine, rabbit atg; Cyclophosphamide, fludarabine, thymoglobulin; Fludarabine (flu); Fludarabine, cyclophosphamide; Fludarabine/ melphalan; Fludarabine/busulfan; Busulfan, fludarabine and atg; Busulfan, fludarabine, atg, tli; Campath, fludarabine, cyclophosphamide; Fludarabine phosphate 30 mg; Fludarabine phosphate 40 mg; Fludarabine, busulfan, thymoglobulin; Fludarabine, melphalan, thiotepa; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan; Cyclophosphamide, fludarabine; Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen);   D01907
 D07966 
 1件: RRM1   2件: Purine metabolism, Pyrimidine metabolism   17件:
13,
28,
36,
46,
49,
51,
60,
61,
62,
65,
85,
96,
164,
283,
284,
285,
326
 42   Fresolimumab  1件: Fresolimumab;   D09620   3件: TGFB1, TGFB2, TGFB3   3件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, TGF-beta signaling pathway   4件:
51,
85,
222,
274
 43   Glycyrrhizic acid  0件:   D00157   -   -   1件:
51
 44   Human interleukin-2  3件: Human interleukin-2; Recombinant human interleukin-2 (rhil-2); Anti-human interleukin-23 monoclonal antibody;   -   -   -   14件:
2,
13,
35,
46,
49,
51,
55,
56,
63,
65,
95,
96,
97,
271
 45   Ifetroban  2件: Ifetroban; Oral ifetroban;   D04500   1件: TBXA2R   2件: Neuroactive ligand-receptor interaction, Platelet activation   3件:
51,
86,
113
 46   Iloprost  21件: Iloprost; Iloprost injection, for intravenous use; Iloprost low dose; Iloprost sale di trometamolo; Iloprost therapy up to 2 ng/kg x min; Iloprost trometamol; Iloprost inhalation solution (ventavis); Aerosolized iloprost; Commercial ventavis® (iloprost); Iloprost (5 µg); Iloprost (ventavis bayq6256); Iloprost (ventavis inhaled, bayq6256); Iloprost (ventavis, bayq 6256); Iloprost (ventavis, bayq6256); Iloprost (ventavis®); Iloprost pd-15; Iloprost pd-6; Iloprost,(ventavis, bayq6256); Inhaled iloprost (ventavis, bayq6256); Ventavis (iloprost, bayq6256); Ventavis(iloprost);   D02721   1件: PTGIR   3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   4件:
51,
84,
85,
86
 47   Imatinib  6件: Imatinib; Imatinib mesilate; Imatinib mesylate; Imatinib mesylate (gleevec); Bevacizumab (avastin) and imatinib mesylate (gleevec); Imatinib mesylate 400mg capsule;   D01441
 D08066 
 3件: ABL1, KIT, PDGFRA   3件: Chronic myeloid leukemia, MAPK signaling pathway, Pathways in cancer   11件:
13,
28,
34,
35,
46,
51,
85,
86,
87,
89,
162
 48   Immune Globulin Human  0件:   -   -   -   20件:
2,
11,
13,
14,
17,
18,
35,
38,
39,
43,
45,
49,
50,
51,
63,
65,
85,
164,
296,
309
 49   Indole  2件: 1-(6-benzothiazolylsulfonyl)-5-chloro-1h-indole-2-butanoic acid; Indole;   -   -   -   1件:
51
 50   Lactic acid  3件: L-lactic acid; Lactic acid; Lactic acid producing organisms;   D00111   -   -   3件:
51,
265,
299
 51   Leuprolide  11件: Leuprolide; Depot leuprolide acetate 3.75 mg; Leuprolide (gnrh agonists); Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate);   D00989
 D08113 
 1件: GNRHR   2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction   5件:
1,
2,
3,
51,
76
 52   Macitentan  8件: Macitentan; Act-064992 (macitentan); Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Fdc macitentan/tadalafil; Macitentan 10 mg; Macitentan 10 mg tablet, once daily.; Macitentan group; Opsumit (macitentan);   D10135   2件: EDNRA, EDNRB   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   5件:
51,
85,
86,
88,
210
 53   Methotrexate  81件: Methotrexate; Intrathecal methotrexate; Methotrexate treatment; Mycophenolate mofetil,methotrexate; Methotrexate 2.5 mg; Methotrexate 25 mg; Abatacept (aba) + methotrexate (mtx), double-blind (db); Abatacept + methotrexate; Adalimumab with methotrexate; Bms-582949 and methotrexate; Certolizumab pegol + methotrexate (mtx); Cp-690,550 + methotrexate; Etanercept + methotrexate; Etanercept , methotrexate; Infliximab + methotrexate (mtx); Infliximab, methylprednisolone, methotrexate; Methotrexate 'lederle' 2,5mg tablets; Methotrexate 'lederle' 2.5mg tablets; Methotrexate (metoject® prefilled pen); Methotrexate (mtx); Methotrexate + biologic administration; Methotrexate + infliximab; Methotrexate + methylprednisolone; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate - amneal; Methotrexate - dava; Methotrexate - delay; Methotrexate - etanercept - prednisolone arm; Methotrexate - immediate; Methotrexate 2.5 mg tablets; Methotrexate 2.5mg tablets; Methotrexate 2.5mg tablets bp; Methotrexate 50mg/ml solution for injection, pre-filled syringe; Methotrexate as methotrexate disodium; Methotrexate capsules; Methotrexate disodium; Methotrexate pfizer 2,5 mg tabletter; Methotrexate placebo; Methotrexate plus enbrel or enbrel alone; Methotrexate plus erb-041 for 12 weeks; Methotrexate plus sulfasalazine; Methotrexate pre-filled pen; Methotrexate prefilled pen; Methotrexate prefilled syringe; Methotrexate sodium; Methotrexate sodium 2.5mg tablets; Methotrexate sodium tablets 2.5 mg; Methotrexate(mtx); Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol.; Methotrexate(necessary); Methotrexate*100cpr 2,5mg; Methotrexate, leucovorin and bms-986142; Methotrexate,adalimumab; Methotrexate-lachema; Methotrexate-sulfasalazine-hydroxychloroquine; Methotrexate® 2.5 mg tablets; Mp-435(dose1) + methotrexate; Oral methotrexate; Phase 1: methotrexate; Response to anakinra associated with methotrexate; Response to infliximab associated with methotrexate; Stable weekly dose of methotrexate; Tacrolimus with methotrexate; Tasocitinib plus methotrexate; Tocilizumab + methotrexate(mtx); Tocilizumab+methotrexate(mtx); Tofacitinib with methotrexate; Tofacitinib without methotrexate; Urine samples taken to measure methotrexate and its major metabolite 7-oh-methotrexate level; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Methotrexate and folic acid; Methotrexate lachema 5inj. sol; Etanercept, methotrexate, prednisolone; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Azathioprine or methotrexate; Early immunosuppressants (azathioprine, methotrexate); Methotrexate bellon; Methotrexate bellon 25mg/ml; Clobetasol propionate + methotrexate; Treatment with systemic therapy (methotrexate); Cyclosporin, methotrexate (gvhd prophylaxis);   D00142
 D02115 
 2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331
 54   Methylprednisolone  29件: Methylprednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Megadose oral methylprednisolone; Methylprednisolone (drug); Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Methylprednisolone (or other glucocorticoid); Prednisone (and methylprednisolone); Infliximab, methylprednisolone, methotrexate; Methotrexate + methylprednisolone; Administration of rituximab and methylprednisolone; Methylprednisolone (mp); Corticosteroid treatment (methylprednisolone or prednisolone); Methylprednisolone or prednisolone; Methylprednisolone (mp) or prednisone (pred); Methylprednisolone mylan générique; Methylprednisolone pulse; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Methylprednisolone or budesonide; Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Intravenous methylprednisolone; Intravenous (i.v.) methylprednisolone 1000 mg, total 9;   D00407
 D00751
 D00979
 D05000
 D05001
 D05002 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296
 55   Metronidazole  6件: Metronidazole; Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication); 10% metronidazole ointment; Azithromycin + metronidazole; Amoxicillin, metronidazole and tetracycline; Metronidazole capsule 50 mg;   D00409
 D05016
 D05017 
 -   -   8件:
46,
51,
63,
94,
95,
96,
97,
291
 56   Mizoribine  1件: Mizoribine;   D01392   2件: IMPDH1, IMPDH2   2件: Metabolic pathways, Purine metabolism   8件:
46,
49,
51,
53,
66,
94,
222,
224
 57   Mycophenolate mofetil  17件: Mycophenolate mofetil; Mycophenolate mofetil (cellcept); Mycophenolate mofetil [cellcept]; Mycophenolate mofetil (mmf) 3 g/day; Mycophenolate mofetil 2 g/day; Cellcept (mycophenolate mofetil); Mycophenolate mofetil,methotrexate; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Mycophenolate mofetil (mmf); Mycophenolate mofetil plus lower dose of prednisone; Azathioprine or mycophenolate mofetil; Mycophenolate mofetil orally 1000 mg twice a day (bid); Mycophenolate mofetil, low dose steroid; Prednisolone and mycophenolate mofetil; Mycophenolate mofetil(mmf); Cyclosporine combine with mycophenolate mofetil; Prednisone and mycophenolate mofetil;   D00752
 D05094
 D05095 
 2件: IMPDH1, IMPDH2   1件: Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300
 58   Mycophenolic acid  2件: Mycophenolic acid; Mycophenolic acid mofetil;   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   34件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
228,
234,
283,
284,
285,
300
 59   Nilotinib  8件: Cohort 1:nilotinib oral capsules (150mg or 300mg); Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1); Nilotinib; Nilotinib 150mg oral capsule [tasigna]; Nilotinib 300mg oral capsule [tasigna]; Nilotinib 150 mg; Nilotinib hydrochloride monohydrate; Nilotinib (tasigna);   D08953   4件: ABL1, KIT, PDGFRA, PDGFRB   4件: Chronic myeloid leukemia, ErbB signaling pathway, MAPK signaling pathway, Pathways in cancer   5件:
6,
8,
34,
51,
86
 60   Nintedanib  5件: Nintedanib; L01xe31 - nintedanib; Pirfenidone and nintedanib; Pirfenidone or nintedanib; Sub-study: nintedanib;   D10481   8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB   3件: MAPK signaling pathway, Pathways in cancer, VEGF signaling pathway   4件:
51,
85,
89,
228
 61   Nivolumab  1件: Nivolumab;   D10316   1件: PDCD1   3件: Cell adhesion molecules (CAMs), PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway   10件:
13,
26,
41,
46,
49,
50,
51,
53,
96,
97
 62   ORM-12741  1件: Orm-12741;   -   -   -   1件:
51
 63   Omeprazole  19件: Clartihromycin, amoxicillin, and omeprazole; Esomeprazole; Omeprazole; Dimebon + omeprazole; Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Diclofenac + omeprazole; Esomeprazole 20 mg; Naproxen 500 mg tablets (pn 200 minus omeprazole); Pn 200 tablets (500 mg naproxen and 20 mg omeprazole); Omeprazole 20mg; Omeprazole (uk licensed generic product); Omeprazole 20 mg; Omeprazole 40 mg; Rifaximin+omeprazole+miralax; Omeprazole 20mg bid; Omeprazole magnesium; Omeprazole rectally 1mg/kg; Nexium (esomeprazole magnesium); Omeprazole 40mg capsule;   D00455
 D01207
 D05259
 D05261 
 2件: ATP4A, ATP4B   2件: Collecting duct acid secretion, Gastric acid secretion   15件:
6,
8,
13,
46,
51,
85,
96,
97,
98,
225,
271,
282,
294,
298,
299
 64   Ozone  1件: Ozone;   -   -   -   2件:
49,
51
 65   Paquinimod  1件: Paquinimod;   -   -   -   2件:
49,
51
 66   Phosphate ion  0件:   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299
 67   Pirfenidone  6件: Pirfenidone; Pirfenidone and nintedanib; Pirfenidone or nintedanib; Pirfenidoneone; Sub-study: pirfenidone; Pirfenidone 267 mg [esbriet];   D01583   6件: CCL2, IL10, IL1A, IL1B, IL6, TNF   5件: Cellular senescence, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, TGF-beta signaling pathway, TNF signaling pathway   10件:
34,
46,
50,
51,
58,
84,
85,
164,
222,
228
 68   Plerixafor  3件: Plerixafor; Plerixafor for conditioning before hsct.; Plerixafor mobilization of autologous cd117 stem cells;   D08971   1件: CXCR4   3件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Pathways in cancer   4件:
51,
65,
285,
299
 69   Pomalidomide  4件: Pomalidomide; Pomalidomide and dexamethasone; Pomalidomide (cc-4047; Pomalidomide oral product;   D08976   2件: IL6, TNF   6件: Apoptosis, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, TNF signaling pathway   6件:
28,
34,
51,
85,
227,
331
 70   Prednisolone  74件: Prednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Megadose oral methylprednisolone; Methyloprednisolone; Methylprednisolone; Methylprednisolone (drug); Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Peg-liposomal prednisolone sodium phosphate; Prednisolone sodium phosphate; Prednisone/prednisolone; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Intravenous methyl prednisolone; Methyl prednisolone; Methylprednisolone (or other glucocorticoid); Prednisone (and methylprednisolone); Prednisone, methylprednisolone,cyclophosphamides; Infliximab, methylprednisolone, methotrexate; Long-circulating liposomal prednisolone; Methotrexate + methylprednisolone; Methotrexate - etanercept - prednisolone arm; Overencapsulated prednisolone tablets; Paroxetine & prednisolone; Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp; Prednisolone & dipyridamole; Prednisolone 20 mg; Prednisolone 40 mg; Prednisolone 5 mg; Prednisolone tablets bp; Prednisolone tablets usp 5 mg; Prednisolone-dipyridamole; Sulphasalazine + hydroxychloroquine or prednisolone; Trexan+salazopyrin+oxiklorin+prednisolone; Trexan+salazopyrin+oxiklorin+prednisolone + infliximab; Z102 (prednisolone and dipyridamole).; Corticosteroids (prednisone or prednisolone); Oral prednisolone; Administration of rituximab and methylprednisolone; Prednisolone and taper; Etanercept, methotrexate, prednisolone; Methylprednisolone (mp); Prednisolone + mabthera; Corticosteroid treatment (methylprednisolone or prednisolone); Methylprednisolone or prednisolone; Methylprednisolone (mp) or prednisone (pred); Methylprednisolone mylan générique; Methylprednisolone pulse; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Prednisone or prednisolone; Azd4017 and prednisolone; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Prednisolone 1mg tablets; Prednisolone 5mg tablet; Glucocorticoid (prednisone or prednisolone); Low dose prednisolone; Medium dose prednisolone; Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Corticosteroid (prednisolone); Prednisolone sodium succinate; Methylprednisolone or budesonide; Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Prednisolone sodium metasulphobenzoate; Prednisolone tablets b.p. 5mg; Intravenous methylprednisolone; Pyridoxine plus prednisolone; Soluble prednisolone tablets; Intravenous (i.v.) methylprednisolone 1000 mg, total 9; Prednisolone acetate; Prednisolone and chlorambucil; Prednisolone and mycophenolate mofetil;   D00472
 D00980
 D00981
 D00982
 D01239
 D01998
 D02156
 D03301 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300
 71   Prednisone  59件: Prednisone; Prednisone - azathioprine; Prednisone alone; Granulocyte-colony stimulating factor (g-csf) and prednisone; Prednisone/prednisolone; Prednisone acetate; Prednisone, cyclophosphamide; Over encapsulated prednisone; Prednisone and ustekinumab treatment; Prednisone capsules; Prednisone tablets usp, 1 mg; Prednisone tablets usp, 2.5 mg; Prednisone tablets usp, 5 mg; Prednisone tablets, usp; Prednisone therapy and pharmacokinetic; Prednisone treatment; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Prednisone (and methylprednisolone); 0 mg prednisone; 5 mg prednisone; Methylprednisone; Prednisone 15 mg; Prednisone 5 mg; Prednisone 7.5 mg; Rayos (delayed-release prednisone); Corticosteroids (prednisone or prednisolone); Cyclophosphamide-prednisone-azathioprine; Oral prednisone 5mg; Prednisone discontinuation; Chinese herb prescription granule plus prednisone; Enalapril valsartan methylprednisone; Hormone (prednisone); Leflunomide 20 mg+prednisone 0.5mg/kg/d; Methylprednisolone (mp) or prednisone (pred); Mycophenolate mofetil plus lower dose of prednisone; Prednisone + inhibace/cozaar; Prednisone and cyclophosphamide; Prednisone arrow 20mg; Prednisone arrow 5 mg; Prednisone in full dose; Prednisone or prednisolone; Prednisone plus cyclophosphamide; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Glucocorticoid (prednisone or prednisolone); Hydroxychloroquine + prednisone; Azathioprine/prednisone; 5-asa, prednisone, azathioprine or remicade; 5-aminosalicylic acid(5-asa) and/or prednisone; Treatment systemic therapy (prednisone); Treatment with systemic therapy (prednisone); Prednisone 0,5 mg/kg orally on alternate days; Prednisone, fk506, mmf; Tacrolimus combined with prednisone; Prednisone acetate tablets; Oral prednisone; Sotatercept with prednisone boost; Prednisone and mycophenolate mofetil; Thalidomide, cyclophosphamide and prednisone;   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   44件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331
 72   Prucalopride  2件: Prucalopride; Prucalopride succinate;   D09205   1件: HTR4   2件: Neuroactive ligand-receptor interaction, Serotonergic synapse   3件:
13,
51,
96
 73   Rabbit  16件: Antithymocyte immunoglobulin (rabbit); Rabbit; Rabbit human t lymphocyte immunoglobulin; Rabbit anti-thymocyte globulin; Rabbit antithymocyte globulin; Anti-human t-lymphocyte immunoglobulin from rabbits; Anti-thymocyte globulin, rabbit; Anti-thymocyte globulin (rabbit); Antithymocyte globulin (rabbit); Cyclophosphamide, fludarabine, rabbit atg; Rabbit anti-thymocyte globulin (atg); Rabbit antithymoglobulin (atg); Rabbit atg; Rabbit atg, (genzyme); Rabbit atg, cyclosporine, levamisole; Rabbit atg, thymoglobuline (genzyme);   -   -   -   7件:
13,
49,
51,
60,
65,
96,
285
 74   Rabeprazole  1件: Rabeprazole;   D00724
 D08463 
 2件: ATP4A, ATP4B   2件: Collecting duct acid secretion, Gastric acid secretion   2件:
2,
51
 75   Regramostim  0件:   D05712   -   -   4件:
11,
46,
51,
229
 76   Rilonacept  3件: Rilonacept; Rilonacept 160 mg; Rilonacept (il-1 trap);   D06635   2件: IL1A, IL1B   4件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Toll-like receptor signaling pathway   4件:
51,
106,
107,
266
 77   Riociguat  12件: Riociguat; Riociguat (adempas, bay63-2521); Riociguat coated tablet 0.5 mg; Riociguat coated tablet 1.0 mg; Riociguat coated tablet 1.5 mg; Riociguat coated tablet 2.0 mg; Riociguat coated tablet 2.5 mg; Adempas (riociguat, bay63-2521); Riociguat (bay63-2521); Riociguat granules 0.3% for oral application; Riociguat oral product; Riociguat pill;   D09572   3件: GUCY1A1, GUCY1A2, GUCY1B1   2件: Platelet activation, Vascular smooth muscle contraction   6件:
51,
84,
86,
88,
225,
299
 78   Rituximab  52件: Rituximab; Rituximab (rituxan); Mabthera (rituximab); Mabthera or biosimilar rituximab product; Rituximab infusion; Rituximab it; Rituximab iv; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Rituximab (mabthera® or rituxan®).; Rituximab and cyclophosphamide iv; Rituximab (arm a); Rituximab (arm b); Abatacept, rituximab or tocilizumab; Abp 798 - biosimilar to rituximab; Gp2013 - a proposed biosimilar rituximab; Idec-c2b8 (rituximab); Mabthera® (rituximab); Originator rituximab - rituxan ® or mabthera ®; Rituxan (inn: rituximab), brand name in the united states; Rituxan® (rituximab); Rituximab - mabthera; Rituximab [mabthera/rituxan]; Rituximab [mabthera]; Rituximab mabthera; Rituximab, mtx, folic acid; Rituximab, observational study amon patients with active ra; Rituximab-eu+ rituximab-pfizer x 2 courses; Rituximab-pfizer (pf-05280586) x 3 courses; Rituximab-us + rituximab-pfizer x 2 courses; Sait101 (proposed rituximab biosimilar); Individualized dose of rituximab; Rituxan (rituximab); Standard dose of rituximab; Administration of rituximab and methylprednisolone; Rituximab (anti-cd20); Alemtuzumab and rituximab; Bendamustine, rituximab; Mabthera or biosimilar rituximab; Rituximab (mabthera®); Alemtuzumab, rituximab; Dexamethasone and rituximab; Rhtpo in combination with rituximab; Immunosuppressive treatment (eg, rituximab); Rituximab (rtx) and azathioprine (aza); Intravenous rituximab; Combined plasma exchange (pex), rituximab, and corticosteroids; The standard steroid treatment, plasma exchange and rituximab; Rituximab 1g iv; Rituximab combined with omalizumab; Experimental (non immunosuppressive symptomatic treatment (nist) and rituximab); Rituximab/ mabthera; Rituximab or rituximab hyaluronidase human;   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331
 79   Rosemary  1件: Rosemary;   -   -   -   1件:
51
 80   Rosuvastatin  6件: Rosuvastatin; Rosuvastatin calcium; Calcium rosuvastatin; Crestor tablets (calcium rosuvastatin) film-coated tablets; Rosuvastatin 20mg; Rosuvastatin 10 mg;   D01915
 D08492 
 1件: HMGCR   1件: Terpenoid backbone biosynthesis   8件:
6,
46,
49,
51,
79,
96,
271,
299
 81   Selexipag  4件: Selexipag; I.v. selexipag; Oral selexipag (uptravi); Selexipag (uptravi);   D09994   1件: PTGIR   3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   5件:
51,
70,
84,
86,
88
 82   Sildenafil  25件: Sildenafil; 5% sildenafil cream; Sildenafil 20mg; Sildenafil 20mg and bosentan 62.5mg; Sildenafil citrate; Sildenafil therapy; Sildenafil (50 mg); Sildenafil and losartan; 20 mg sildenafil citrate by mouth; Access program - sildenafil citrate, viagra, revatio; Bosentan and sildenafil; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Oral sildenafil; Sildenafil (as citrate); Sildenafil (revatio); Sildenafil (revatio) 20 mg tid; Sildenafil citrate (uk-92,480); Sildenafil singly or in association with bosentan; Sitaxsentan and sildenafil; Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth; Tadalafil and sildenafil; Sildenafil 20 mg tablets; Acute (1 hour) sildenafil; Sildenafil 40mg oral capsule; Sub-chronic (4 weeks) sildenafil;   D02229
 D08514 
 1件: PDE5A   1件: cGMP-PKG signaling pathway   16件:
6,
46,
50,
51,
85,
86,
96,
113,
210,
211,
212,
225,
226,
278,
294,
299
 83   Simvastatin  16件: Simvastatin; Simvastatine; Encapsulated simvastatin tablets; Simvastatin 40 mg film-coated tablets; Simvastatin alternova; Simvastatina; Simvastatina sandoz 40 mg comprimidos recubiertos con película efg; Simvastatine sandoz 40 mg filmomhulde tabletten; Simvastatine sandoz 40mg deelbare filmomhulde tabletten; Simvastatin 20mg/5ml oral suspension; Ezetimibe+simvastatin drug combination; Simvastatin 40mg; Simvastatin-ratiopharm; Simvastatin-ratiopharm®; Simvastatin treatment for 28 days; Simvastatin susp.;   D00434   1件: HMGCR   1件: Terpenoid backbone biosynthesis   19件:
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310
 84   Sirolimus  16件: Sirolimus; Temsirolimus; Temsirolimus tablets; Sirolimus 2 mg; Skincerity plus sirolimus/rapamycin; Skinercity plus sirolimus/rapamycin; Sirolimus (formerly known as rapamycin); Sirolimus 2%; Sirolimus, 2%; Rapamycin, sirolimus; Sirolimus and hydroxychloroquine; Sirolimus 0.2%; Sirolimus 0.4%; Sirolimus 0,1% crème; Sirolimus oral liquid product 1mg/ml; Topical 0.1% sirolimus;   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   36件:
2,
13,
15,
17,
34,
35,
36,
46,
49,
51,
60,
61,
62,
63,
65,
66,
67,
85,
86,
89,
96,
98,
137,
157,
158,
192,
222,
256,
277,
278,
279,
280,
281,
283,
285,
331
 85   Sodium chloride  14件: 0.9% sodium chloride; 0.9% sodium chloride (normal saline); Sodium chloride; Sodium chloride solution; Isotonic sodium chloride solution; 0.9% sodium chloride injection; Physiological serum (sodium chloride); Sodium chloride solvent; Sodium chloride solution 0.9%; 0.9% w/v sodium chloride solution; Sodium chloride (7%); Sodium chloride 0,9%; Sodium chloride 6%; Sodium pyruvate in 0.9% sodium chloride solution;   D02056   -   -   19件:
6,
11,
13,
14,
17,
34,
46,
51,
53,
67,
78,
86,
97,
168,
193,
227,
228,
288,
299
 86   Sodium fluoride  2件: Sodium fluoride; Sodium fluoride 18f;   D00943   -   -   2件:
13,
51
 87   Tacrolimus  13件: Tacrolimus; Tacrolimus capsule; Interferon beta-1b and tacrolimus; Non-mtx dmards (e.g. sulfasalazine, leflunomide, bucillamine, tacrolimus, or mizoribin); Tacrolimus (prograf®); Tacrolimus with methotrexate; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Lcp-tacro (tacrolimus); Rectal tacrolimus; Tacrolimus capsules; Tacrolimus combined with prednisone; Tacrolimus and mmf; Tacrolimus prolonged-release hard capsules;   D00107
 D08556 
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   30件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
86,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299
 88   Tadalafil  11件: Tadalafil; Tadalafil and ambrisentan upfront combination therapy; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Fdc macitentan/tadalafil; Tadalafil 20 mg film-coated tablets; Tadalafil 40 mg; Tadalafil oral suspension; Tadalafil, placebo; Tadalafil- tablet or oral suspension; Tadalafil 20 mg; Tadalafil and sildenafil;   D02008   1件: PDE5A   1件: Purine metabolism   6件:
6,
51,
75,
84,
86,
113
 89   Terguride  3件: Terguride; Terguride hydrogenmaleate; Terguride 0.5 mg tablet;   D01348   2件: DRD2, PRL   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Prolactin signaling pathway   2件:
51,
86
 90   Thalidomide  9件: Thalidomide; Thalidomide (drug); Fpf 300 (thalidomide); Melphalan, thalidomide and dexamethasone; Thalidomide pharmion; Thalidomide celgene - 50 mg capsula rigida - uso orale - blister (pvc/pe/aclar/alu) 28 capsule; Thalidomide 100mg; Thalidomide 150mg; Thalidomide, cyclophosphamide and prednisone;   D00754   1件: TNF   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, NF-kappa B signaling pathway, TNF signaling pathway   18件:
2,
16,
20,
28,
49,
51,
53,
65,
84,
85,
94,
96,
97,
227,
271,
280,
298,
331
 91   Thiotepa  5件: Thiotepa; Thiotepa--escalated dose; Thiotepa--single daily dose; Fludarabine, melphalan, thiotepa; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan;   D00583   -   -   11件:
13,
19,
20,
28,
51,
60,
65,
85,
96,
164,
284
 92   Tocilizumab  26件: Tocilizumab; Tocilizumab injection; Tocilizumab (mra-sc); Corticoids+ tocilizumab 8mg/kg/4 weeks; Tocilizumab + glucocorticoids (gcs); Tocilizumab sc; Tocilizumab treatment; Abatacept, rituximab or tocilizumab; Decrease tocilizumab, abatacept; Intra-articular tocilizumab; Mra (tocilizumab); Mra(tocilizumab); Subcutaneous tocilizumab; Tocilizumab (actemra®); Tocilizumab + methotrexate(mtx); Tocilizumab 162 mg; Tocilizumab 162mg/0.9ml jeringa sc; Tocilizumab [roactemra/actemra]; Tocilizumab [roactemra]; Tocilizumab prefilled syringe; Tocilizumab+methotrexate(mtx); Tocilizumab, abatacept; Tocilizumabum; Tocilizumab sc 162 mg/0.9 ml prefilled syringe with safety device (pfs); Inn-tocilizumab; Tocilizumab infusion roacemtra (eu);   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   16件:
2,
13,
40,
41,
43,
46,
50,
51,
53,
54,
55,
86,
107,
266,
271,
331
 93   Tofacitinib  23件: Chong kun dang tofacitinib tablet; Cp-690,550 (tofacitinib); Tofacitinib; Tofacitinib (xeljanz); Tofacitinib 5 mg; Tofacitinib 5 mg [xeljanz]; Tofacitinib 5mg po bid; Tofacitinib citrate; Tofacitinib citrate (clinical trial image); Tofacitinib citrate (commercial image); Tofacitinib citrate cp-690550; Tofacitinib with methotrexate; Tofacitinib without methotrexate; Tofacitinib/baricitinib; Tofacitinib 5 mg twice daily; Tofacitinib 5mg [xeljanz] 1 year open-label extension; Tofacitinib 5mg oral tablet [xeljanz] 16 week trial; 15n2-tofacitinib; Tofacitinib citrate (proposed commercial formulation – debossed); In double-blind phase: treatment with tofacitinib; In open-label phase: treatment with tofacitinib; Tofacitinib 10 mg; Tofacitinib 2 mg;   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   9件:
46,
49,
50,
51,
84,
96,
97,
107,
271
 94   Treprostinil  32件: Iontophoresis of treprostinil; Oral treprostinil; Treprostinil; Treprostinil diethanolamine; Inhaled treprostinil; Treprostinil sodium for inhalation; Eutonic treprostinil solution; Hypotonictreprostinil solution; Inhaled dry powder treprostinil (liq861); Intravenous treprostinil; Intravenous/subcutaneous treprostinil; Liq861 inhaled treprostinil; Oral treprostinil (ut-15c) sustained release tablets; Parenteral remodulin (treprostinil) injection; Rapid dose titration group of subcutaneous treprostinil; Remodulin (treprostinil sodium); Remodulin® (treprostinil) 1 mg/ml solution for infusion; Remodulin® (treprostinil) 10 mg/ml solution for infusion; Remodulin® (treprostinil) 2.5 mg/ml solution for infusion; Remodulin® (treprostinil) 5 mg/ml solution for infusion; Slow dose titration group of subcutaneous treprostinil; Subcutaneous treprostinil; Treprostinil diolamine; Treprostinil inhalation powder; Treprostinil inhalations; Treprostinil injectable product; Treprostinil sodium; Treprostinil sodium solution for inhalation; Treprostinil sodium, ut-15; Treprostinil, ut-15, lrx-15, 15au81, bw a15au, u-62, 840; Ut-15c (treprostinil diethanolamine); Ut-15c sr (treprostinil diethanolamine);   D06213   1件: PTGIR   3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   5件:
51,
84,
85,
86,
88
 95   Trimebutine  1件: Trimebutine;   D08639   2件: OPRK1, OPRM1   1件: Neuroactive ligand-receptor interaction   1件:
51
 96   Tromethamine  2件: Ketorolac tromethamine; Tromethamine;   D00396   -   -   3件:
51,
226,
299
 97   Yellow Fever Vaccine  2件: Yellow fever vaccine; Yellow fever vaccine (17d);   D06347   -   -   7件:
40,
44,
46,
50,
51,
52,
53
 98   Zinc acetate  3件: Zinc acetate; Zinc acetate dihydrate; Zinc acetate (20mg/d);   D06408   -   -   7件:
49,
51,
70,
86,
171,
256,
299

先頭へ